Related Experiment Video
Updated: Jan 17, 2026

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
Macrophage profiles in drug-resistant tuberculosis patients and their close contacts: A pilot study
Diah Handayani1, Muhammad Faris Indratmo2, Ardiana Kusumaningrum3
1Department of Pulmonology, Faculty of Medicine, Universitas Indonesia, Universitas Indonesia Hospital, 10430, Indonesia.
Abstract:
Macrophages play a key role in controlling tuberculosis infection. This pilot study aimed to analyze the macrophage profile in drug-resistant tuberculosis patients compared to a group of close contacts diagnosed with latent infection and a group of healthy. The Interferon Gamma Release Assay (IGRA) was tested on the close contact group to determine their infection status. PBMCs were cultured using RPMI 1640 medium with M-CSF and autologous serum, incubated for 7 days at 37oC with 5 % CO2 Incubator. Macrophage profiles were analyzed using the flow cytometry technique with CD68+, CD80+, CD206+ markers, and the cytokine profiles were analyzed using multiplex immunoassay. The results of the IGRA showed that of the 18 close contact subjects, 8 subjects (44.4 %) were declared latent infected (LTBI) and 10 subjects (55.6 %) were declared healthy. The results showed that the macrophage population exhibit CD206+ expression in each group, which showed a tendency for macrophages toward the M2 type (Kruskal-Wallis, p > 0.05). Cytokine examination showed high IL-10 levels in each group (Kruskal-Wallis, p > 0.05). This research is expected to provide information regarding the characteristics of macrophages as components of innate immune cells which have an important role in tuberculosis infection.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

